ABSTRACT: Previous studies have documented the effectiveness of porcine somatotropin (pSTI administered by daily injection in promoting lean tissue growth in lean and obese pigs and the influence of sex and genotype. The present study examined the accretive responses in pigs of different lines and sexes to a slow release formulation of pST (pST-SRI. Implants that deliver 2.0 mg of pST/d were implanted in genetically lean and obese barrows and gilts at 65 i .7 kg BW (mean i SEI. Pigs received no, one, or two implants Ke., doses of 0, 2.0, and 4.0 mg of pST/dI. Pigs (four per line x sex x dose) were housed individually and continuously supplied with fresh water and a 19% CP diet containing 1.08O/0 lysine. Pigs were slaughtered on d 0 (four per line x sex) and at the end of the trial (approximately 42 d after implantation) for estimation of initial composition and calculation of accretion rates. Blood samples were collected at d 0,7, 14,28, and 42 to measure endocrine and metabolite responses to pST-SR. Sustainedrelease pST elevated (P < .05) circulating pST throughout the trial with peak concentrations a t d 7. On d 7, serum pST concentrations in the pigs given 2.0 mg of pST-SR per day were 10-fold greater than those in control pigs, and in pigs given 4.0 mg of pST-SR per day pST concentrations were 33-fold greater than in controls.
ABSTRACT: Previous studies have documented the effectiveness of porcine somatotropin (pSTI administered by daily injection in promoting lean tissue growth in lean and obese pigs and the influence of sex and genotype. The present study examined the accretive responses in pigs of different lines and sexes to a slow release formulation of pST (pST-SRI. Implants that deliver 2.0 mg of pST/d were implanted in genetically lean and obese barrows and gilts at 65 i .7 kg BW (mean i SEI. Pigs received no, one, or two implants Ke., doses of 0, 2.0, and 4.0 mg of pST/dI. Pigs (four per line x sex x dose) were housed individually and continuously supplied with fresh water and a 19% CP diet containing 1.08O/0 lysine. Pigs were slaughtered on d 0 (four per line x sex) and at the end of the trial (approximately 42 d after implantation) for estimation of initial composition and calculation of accretion rates. Blood samples were collected at d 0,7, 14,28, and 42 to measure endocrine and metabolite responses to pST-SR. Sustainedrelease pST elevated (P < .05) circulating pST throughout the trial with peak concentrations a t d 7. On d 7, serum pST concentrations in the pigs given 2.0 mg of pST-SR per day were 10-fold greater than those in control pigs, and in pigs given 4.0 mg of pST-SR per day pST concentrations were 33-fold greater than in controls.
Elevated serum pST resulted in increased [P < .051 serum concentrations of insulin-like growth factor (IGFI-I, IGF-11, insulin, and glucose and in reduced (P e .05) concentrations of urea nitrogen and IGF binding protein IIGFBPI-2. Gain was not influenced by pST-SR dose; however, feed consumption was reduced (P e .05) and efficiency of gain was increased (P < ,051. Accretion of all body compo nents except cold carcass weight, cecum, and untrimmed Boston butt and ham were changed (P < .05) with pST-SR administration. Heart and stomach were the only components of the carcass and offal whose accretion was not affected by line or sex. Increases in accretion of carcass components ( < 75%) induced by sustained-release pST were considerably less than those measured in the organs (liver, 157%; lungs, 748%). The pST-SR treatment resulted in elevated serum concentra
Introduction
Numerous workers have confirmed the work of Machlin (19721, who demonstrated that administration of porcine growth hormone (pGH) or porcine somatotropin (pSTI improves the rate, composition, and efficiency of growth in pigs (Etherton et al., 1987; Evock et al., 1988; Yen et al., 1990a) . Previous work in our laboratory has established that growth rate and efficiency and carcass characteristics of genetically lean and obese lines of swine are significantly improved by daily administration of pST Wen et al., 1990a) . It has been reported that obese pigs have lower circulating concentrations of pST than do pigs of the lean line (Althen and Gerrits, 1976a,b; Stone et al., 1985;  Yen et at., 199Oa). Gilts and barrows of these selected lines of lean and obese pigs provide models with contrasting degrees of fatness and endogenous concentrations of pST.
Previously, pST had to be administered via frequent injections, generally daily, to obtain increased growth performance. Recently, pST became available as a sustained release formulation (pST-SR), which allows administration once every 6 wk (Knight et al., 1988 ). An advantage of this formulation is the reduced effort required for administration of pST to pigs throughout a finishing period. However, a biological consequence, which may be significant, is sustained elevated concentrations of pST rather than one daily peak of pST of extreme amplitude.
The present study was designed to compare responses in growth performance and carcass characteristics and some endocrine and metabolite measures in gilts and barrows of the genetically lean and obese lines to sustained release of PST (pST-SRI.
Materials and Methods
Genetically lean and obese gilts and barrows (approximately 60 kg BW, 166 d of age) used in the present study were from inter se matings of crossbreds produced by within-line matings of purebred Duroc and Yorkshire pigs selected solely for high and low backfat thickness over multiple generations (Hetzer and Harvey, 1967) . Porcine somatotropin was administered to the pigs via a sustained release implant designed to deliver approximately 2.0 mg of monomeric recombinant pST per day (Knight et al., 1988; Azain et al., 1990 Using a trocar (8 mm o.d.1, the implants were placed subcutaneously in a caudal location at the base of the ear using aseptic techniques. The area of trocar insertion was scrubbed with an antiseptic soap and dried with a clean tissue. An antiseptic ointment was applied to the insertion site after implantation. This method of implantation precluded abscess problems. The trocar was inserted subcutaneously into control (0 mg pST-SR) pigs; however, no implant was inserted. The study consisted of 48 pigs assigned to 12 treatment groups in a 2 x 2 x 3 factorial arrangement of treatments: two lines, two sexes, and three doses of pST. Four pigs from each line x sex group were slaughtered at the initiation of the study to estimate initial body component weights of the pigs.
During the study, pigs were maintained in individual slotted-floor pens (1.2 m x 1.2 ml in an enclosed, temperature-controlled building with free access to water and feed. Feed was a 19% CP corn-soybean meal diet meeting or exceeding the NRC nutrient requirements (NRC, 1988) . Calculated lysine content of the diet was 1.08%. Pigs were weighed at the start of the study and every 14 d thereafter. At each weighing, backfat thickness was determined ultrasonically (Scan-0-Probe", Ithaco, Ithaca, NY) at three sites: first rib, last rib, and last lumbar vertebrae. These three values were averaged to obtain average backfat thickness. At slaughter, live weight, hot carcass weight, and the weights of various offal components were collected. Approximately 24 h after slaughter, chilled carcass weight was determined, backfat thickness was measured at first rib, last rib, and last lumbar vertebrae, and the left side was dissected into the primal cuts. The three backfat values were averaged to obtain average carcass backfat thickness. The primal cuts were weighed and, with the exception of the belly, trimmed to approximately 6 mm of fat and again weighed. The trimmed weights of the picnic, Boston butt, loin, and ham were summed to obtain the value for trimmed primal cuts. The left ham was dissected into lean tissue, bone, and fat (including skin). The total cross-section of the untrimmed loin between ribs 10 and 11, included bone, muscle, fat, and skin, and the area of the longissimus muscle were traced and the areas were measured using computerized planimetery (Bioquant IV System@, R&M Biometrics, Nashville, TNI. Similar data were collected from the pigs killed at the beginning of the study.
Blood samples were collected via venipuncture of the jugular vein before implantation of the sustained release implants, and on d 7, 14, 28, and at the end of the trial. Blood samples were immediately placed in ice, and the serum was separated after centrifugation within 4 to 6 h after collection. Serum concentrations of pST, insulin, insulin-like growth factor (IGFI-I, IGF-11, and IGF binding protein-2 (IGFBP-2) were determined by RIA (Klindt et al., 1983; Buonomo et al., 1987 Buonomo et al., , 1988 Buonomo and Baile, 1991;  Buonomo and Klindt, 1992;  respectively). Serum glucose and urea nitrogen were determined by spectrophotometric methods (Yen et al., 1990bl. Accretion of the offal and carcass components for the 42-d treatment period were estimated for each pig from the difference in the measures at completion of the study and the predicted measures at initiation of the trial. Initial component measures were predicted from data obtained from pigs killed at the beginning of the study.
The data were analyzed using the GLM procedure of SAS (1989) . Average daily gain and average daily change in backfat thickness were determined by regression. The model for analysis of growth performance, tissue weights, and accretion estimates consisted of the main effects of line or genotype, sex, pST-SR dose, and resulting interactions with initial weight included as a covariate term. Sums of squares were partitioned into single degree of freedom contrasts to examine the linear and quadratic effects of pST-SR dose. Temporal concentrations of serum constituents were examined by split-plot analysis of variance. The model consisted of the effects of pST-SR dose, line, sex, and resulting interactions tested by pig within pST-SR dose x line x sex and effects of time and the interactions of the effects included in the subplot with time tested by the remaining variation. Sums of squares for dose were partitioned into single degree of freedom contrasts to examine the linear and quadratic effects of dose of pST-SR.
Results
Growth performance of lean and obese gilts and barrows was significantly influenced by pST-SR administration ( Table 1) . In general, feed consumption was reduced and ADG was unchanged, and thus efficiency of gain was increased with increasing dose of pST-SR. The dosedependent response in feed intake to increasing dose of pST-SR, 0 to 4.0 mg/d, was negative, without a suggestion of a quadratic component (P > .lo). Efficiency of gain increased significantly, in a manner suggesting a quadratic response, with increasing dose of pST-SR. These changes in feed consumption and efficiency of gain were not influenced by sex or line. Daily change in average backfat thickness was reduced with increasing pST-SR dose (P e .05) and influenced by interactions with line (P < .05) and sex (P = .lo, Figure I ). Overall, the dose response was linear without suggestion of a quadratic component. In obese barrows receiving the high dose of pST-SR, the daily change in average backfat thickness was negative (i.e., backfat thickness was reduced during the trial). In contrast, the backfat thickness response in lean gilts, the group that was initially the leanest, was nil.
Weights of most body components were significantly influenced by pST-SR administration ( Table  2) . In general, the proportional changes in wholebody measures were small, intermediate in the carcass components, and large in the offal (organ) components. Several of the muscle measure responses (Le., longissimus muscle area and weights of picnic and trimmed picnic, trimmed loin, trimmed ham, and trimmed primal cuts) suggested a quadratic response to dose of pST-SR. In contrast, no suggestions of quadratic responses to dose of pST-SR were observed in the significant increases in organ weights. The effect of line on tissue measures was significant for most body components. Exceptions were Boston butt, stomach, and small intestine. The influence of sex was significant for average carcass backfat thickness and spleen. Estimates of accretion of body components, in general, present information similar to that obtained from the tissue and organ weights at slaughter (Table 31. Serum concentrations of pST were influenced by the main effects of dose of pST-SR (P c .05), sex (P = ,081, and the interaction of dose and time (P < .01). Administration of pST via the sustainedrelease device resulted in significantly elevated serum concentrations of pST during the 42-d period. Maximal concentrations were measured on d 7 (Figure 2) . Throughout the trial, pST concentrations decreased in the pST-SR pigs. At the end of the trial there were no differences in pST concentrations between the two pST-SR implanted groups, but levels in both treatment groups were significantly greater than that in the control €TOUP.
Temporal responses of glucose and urea nitrogen to pST-SR were significantly influenced by pST-SR dose and line (Figure 3) . The responses in glucose and urea nitrogen were greatest early in the trial when pST concentrations were the highest. By the end of the trial, glucose concentrations in the pST-SR pigs were similar to those in the untreated control pigs, although pST concentrations were still significantly elevated. Both 
Discussion
Administration of pST via sustained-release implant significantly increased efficiency of gain through decreased feed consumption. There were no changes observed in rate of gain with pST-SR treatment. This is in contrast to results of a 
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KLINDT ET AL. previous study in which administration of pST via daily injection at similar doses resulted in increased efficiency of gain as a consequence of both decreased feed consumption and increased rate of gain in pigs of these genetic lines (Yen et al., 1990a) . It seems that a pSTinduced rate of gain response is dependent on the method of pST delivery. Daily injection of pST results in large daily peaks in the circulating concentrations of pST, which may be required to activate those physiological processes necessary for growth enhancement. There are numerous data that indicate that the pattern of somatotropin (ST) secretion is related to growth and metabolic traits (Jansson et al., 1985; Ford and Klindt, 1989) . Administration of ST to hypophysectomized rats as four injections per day was more efficacious in promoting body growth than was the same dose administered as one, two, or eight injections (Jmsson et al., 19851 . Evock and Steele (1991) reported a positive relationship between the frequency of pST administration and growth rate of pigs injected once per day, once per 2 d, or once per 4 d. Others have observed that administration of ST to rodents by constant infusion elicits a characteristically female response in some liver proteins and enzymes, whereas pulsatile administration elicits a male response (Norstedt and Palmiter, 1984) . Thus, it may not be surprising that the response to pST-SR, a method of continuous administration, is different from the response to daily injection of pST. However, Moseley et al. (19821 observed no effect of pattern of bovine ST administration (constant infusion, 6 pulsedd, or infusion plus pulses) on growth of Holstein steers.
Over the pST-SR dose range used in the present study, responses in feed consumption were linear, with no suggestion of a quadratic component. Lack of a quadratic component in the response in feed consumption is a n artifact of the limited range of doses administered. Improvement in efficiency by increasing the dose from 0 pST-SR/d to 2.0 of pST-SR/d was much greater than that due to increasing the dose from 2.0 mg of pST-SR/d to 4.0 mg of pST-SR/d. In previous work with the genetic lines used herein, pST was administered at similar doses by daily injection (Yen et al., 1990a) . In that study, efficiency of gain changed in a manner suggesting a quadratic response similar to that observed herein.
Effect of pST-SR treatment on changes in accretion of body components during the trial basically followed the pST-SR-related changes in body component weights a t slaughter. However, the proportional responses in accretion of organ weights to pST-SR treatment were considerably greater than the response in accretion of carcass component weights (Figure 8) . Increase in accretion of liver weight with 4.0 mg of pST-SR/d was 157% and that of the lungs approached 750%. These large increases in accretion of visceral organ weight were accompanied by considerably smaller proportional increases in primal cuts (e.g., trimmed Boston butt, 74%; trimmed ham, 65%; trimmed loin, 33%). These results indicate that weights of visceral organs are much more responsive to the stimulatory actions of pST-SR than are the weights of the skeletal muscles. Increased organ weights with pST administration have con- sistently been reported by others (Machlin, 1972; Chung et al., 1985; Kanis et al., 19901 . Positive correlations between organ weights or accretion of organ weight and potential for growth and(or1 production have been found in comparisons of animals performing differently, whether the determinant of differences is genotype, sexual differentiation, or nutritional environment (Ferrell, 1988) . It may be that the metabolic organs must grow to accommodate the demands of increased growth and(or1 production on the metabolic machinery of the animal.
Accompanying increased lean accretion and efficiency of live weight gain were large increases in weights of internal organs (i.e., liver, kidneys, lungs, heart, spleen, stomach, and small intestine]. These increases in weights of internal organs suggest that there was increased energy expenditure for maintenance. Evidence from a number of studies indicates that increases in the mass of these organs are associated with increases in v) cn _-maintenance energy requirements (Ferrell, 1988) . In concurrence, maintenance energy requirements have been estimated to be 9 to 17% greater in pSTtreated than in control pigs (Campbell et al., 1988; Verstegen et al,, 1990 Verstegen et al,, , 1991 Yen et al., 1992) . However, in the present study gross efficiencies of live weight gain (gaidfeed) were increased by 29 and 35% with administration of 2.0 and 4.0 mg of pST-SR/d, respectively. To reconcile these apparently conflicting observations, one must conclude that improvement of efficiency of nutrient utilization, above maintenance, for live weight gain was greater than that observed in gross efficiency estimates. Considering that proportionally more of the carcass was lean marketable cuts, production efficiency of marketable lean pork was increased considerably with administration of pST-SR. 7.6 and 11.5% of the consumed DE as protein. The proportion of the DE retained as protein was 5 0 % greater in pST-treated pigs than in control pigs. Thus, administration of pST acts to increase efficiency of lean pork accretion through increases in efficiency of protein deposition.
Administration of pST-SR had significant effects on most of the carcass measures obtained at slaughter. Cross-sectional area of the untrimmed loin between the 10th and 11th rib was decreased with pST-SR, whereas longissimus muscle area was significantly increased. The decrease in the area of the untrimmed loin cross-section was due to large decreases in backfat thickness. Administration of 2.0 and 4.0 mg of pST-SR/d increased the proportion of the untrimmed loin cross-sectional area represented by the longissimus muscle by 18 and 17% in the lean pigs, respectively. In obese pigs these increases were 29 and 35% for doses of 2.0 and 4.0 mg of pST-SR/d, respectively. The proportional response in this trait was greater in obese pigs than in lean pigs because of the larger longissimus muscle area in the lean pigs. Absolute pST-SR induced increases in longissimus muscle area (square centimeters) were similar in the two lines.
The ability of pST to decrease backfat accretion may be related to initial backfat thickness. Kanis et al. (19901 reported that leaner breeds of swine (Pietrain and Dutch Yorkshire x Dutch Landrace) have reduced responsiveness in backfat to pST compared with a more obese breed (Duroc). Similar results have been obtained comparing Meishan, an obese breed, and Pietrain, a lean breed (Bidanel et al., 1991) . In the present study, rate of backfat deposition was negative in obese barrows administered the high dose of pST-SR (i.e., backfat thickness actually decreased in these pigs during the trial). Despite this, mean average carcass backfat thickness of obese barrows was 4.9 cm at the end of the trial, approximately double the thickness measured in the lean gilts (2.4 cm). Gilts of the lean line were the leanest group initially and did not demonstrate a backfat response to pST-SR. It may be that the carcass backfat the lean gilts maintained is the minimum required for their maintenance of "homeostasis" or their backfat "baseline."
Administration of pST-SR at doses of 2.0 and 4.0 mg/d resulted in mean pST concentrations measured over the entire trial of 8.3 and 14.8 mg/mL. Increasing dose of administered pST-SR twofold resulted in a 1.8-fold increase in circulating pST concentrations, an approximately linear increase. This linear relationship between administered dose of pST-SR and circulating concentrations of pST was primarily due to measurements obtained during the early and mid-portion of the trial, when the implants were releasing pST at a greater rate. At the end of the trial, when the delivery rate of the implants seemed to be reduced, differmces between concentrations of pST measured iai pigs receiving 2.0 or 4.0 mg of pST-SR/d were small. Concentrations of pST in implanted pigs at the end of the trial were significantly elevated above those measured in control pigs, indicating that the sustained-release devices were still releasing pST into the circulation of the pigs. However, the levels at the end of the trial in pigs with 4 mg/d were less than would be predicted from the data from pigs with 2 mg/d. Possible explanations include the possibility that by random chance the implants placed in the pigs with 4 mg/d released at a considerably slower rate than those placed in the pigs receiving 2.0 mg/d, the presence of the higher dosage reduced release from the implant, or clearance of pST was increased by the chronic sustained elevations in circulating pST. The reduced difference in achieved concentrations of pST in the two implanted groups may be due to sustained high circulating concentrations activating clearance mechanisms.
Examination of temporal patterns of circulating pST in those pigs administered pST-SR indicates that the concentrations achieved may have been influenced by line and sex. Analysis of the concentrations of pST in the circulation of treated pigs after adjusting for BW revealed significant interactions of line, sex, and time and line, dose, and time. Possible sources of differences due to dose are presented above. Differences due to line and sex may be due to chance selection of implants of different delivery rates for the different sex and line groups, sex and line may affect release rates of the implants, or sex and line may affect metabolic clearance rate (MCRI of pST. The present observations suggest differences in MCR if one assumes that release of pST from the sustained release implants is consistent across the sex and line groups. Lower concentrations of circulating pST in lean pigs would suggest a greater MCR of pST. Althen and Gerrits (1976b1 reported no Significant differences between these lines of pigs in MCR of pST. However, Arbona et al. (1988) reported greater values for MCR of pST in pigs selected for heavier weight at 200 d of age than in unselected pigs. In male rats, radioiodinated-human ST was internalized in hepatocytes, and ultimately 24% of the dose was found in association with plasma membranes and endocytic structures (Bullier-Picard et al., 1989) . Such internalization would be a significant component of clearance. Although there is not a full understanding of all mechanisms of ST clearance, it would seem reasonable that animals with a greater ability to respond to ST may have greater capability to clear ST. Lean-line pigs normally grow in a manner suggestive of more responsiveness to endogenous pST, with greater lean and less fat deposition.
Serum concentrations of glucose and insulin were increased with pST-SR administration and responses were influenced by line and time. Glucose responses were greatest on d 7 of the trial, when the pST concentrations were the greatest. Porcine ST-induced, dose-dependent, hyperglycemia, and the hyperinsulinemia that is probably a response to the hyperglycemia, have consistently been observed in previous studies ( C h u g et al., 1985; Buonomo et al., 1990; Wray-Cahen et al., 1991) . The hyperglycemic response was greater in genetically obese pigs than in lean pigs, as reported previously (Buonomo et al., 19901 . This pST-induced hyperglycemia could be due to decreased glucose uptake by tissues or to increased output, principally from the liver. WrayCahen et al. (1987) reported that glucose uptake by tissues of pST-treated contemporary crossbred pigs was 25% of that of control pigs. Gopinath and Etherton (1 989) reported significant decreases in glucose clearance and increases in hepatic glucose output in Yorkshire pigs given pST. In genetically obese pigs given pST, fasted (approximately 26 h) glucose concentrations were increased 4 1% , whereas metabolic clearance rates of glucose were unchanged (Klindt et al., 19911. The pST-induced hyperglycemia may be due, in part, to decreased tissue uptake of glucose, but it is also apparent that the mechanisms that maintain serum glucose concentrations (ie., glycogenesis, glycogenolysis, lipogenesis, gluconeogenesis) function in a different manner in pST-treated pigs.
Patterns of serum urea nitrogen in the two lines of pigs were similar but were the inverse of the observations for serum glucose. Decreased serum urea nitrogen reflects increased amino acid uptake and deposition by body tissues. Maximal decrease in serum urea nitrogen was a t d 7 and waned as the trial progressed. However, as in the case of glucose, serum urea nitrogen response to pST-SR administration was greater in obese-line pigs than in lean-line pigs. Greater reduction in urea nitrogen observed in response to pST-SR administration in the obese line pigs is associated with proportionally greater response in lean accretion in obese pigs. For example, accretion of trimmed primal cuts was increased by 74% in obese pigs with 4.0 mg of pST-SR/d, whereas in lean pigs this increase was 38%.
Insulin-like growth factors I and I1 are considered to be the mediators of the growth-promoting actions of pST. In the present study, serum concentrations of IGF-I and -11 were increased in a quadratic manner with increasing dose of pST-SR.
The growth-promoting actions of IGF-I have been demonstrated in hypophysectomized rats and dwarf mice. Administration of 300 pg/d of IGF-I to hypophysectomized rats stimulated BW gain to a degree approaching that of approximately 95 pg/d of human ST (Gular et al., 1988 An IGF-I1 response is not always evident with administration of pST to growing swine Evock et al., 19901 . The growthpromoting actions of IGF-I1 have been demonstrated in hypophysectomized rats (Shaar et al., 19891. Thus, the ultimate quality of the growth response exhibited may be influenced by the IGF-I1 response to pST administration, and the nature of that response may reflect genotype and(or1 environmental factor(s1. However, the IGF-I1 i n creases measured in the present study, in which improvement in rate of gain was not detected, are not appreciably different from those measured in the previous study, in which rate of gain was increased with pST administration (Buonomo et al., 19901. Thus, overt differences in IGF-I1 response do not seem to be associated with the ability to exhibit an improvement in rate of gain with pST administration. Ascribing a pattern of growth response to a particular pattern of IGF response is difficult. Interrelationships among IGF-I, IGF-11, pST levels, line, and sex are complex. Understanding these relationships may be required to obtain optimal growth responses with pST-SR administration.
Concurrent with pST-SR-induced increases in IGF-I, IGF-11, and insulin were decreases in serum IGFBP-2. Although decreased serum concentrations of IGFBP-2 occur with pST-SR administration, they may not be a direct consequence of increased serum concentrations of pST. Insulin is a potent negative regulator of hepatic IGFBP-2 mRNA levels in rat hepatocytes (Boni-Schnetzler et al., 19901, whereas in the same model ST was ineffective in altering hepatic levels of mRNA for IGFBP-2. Camacho-Hubner et al. (19911 recently reported that ST-deficient transgenic mice with elevated concentrations of IGF-I had elevated concentrations of IGFBP-2. Thus, the decreased serum ICFBP-2 concentrations measured in the present study may not be due to elevated circulating pST or IGF-I, but they are probably a consequence of the elevated insulin concentrations. These elevated insulin concentrations are a consequence of the insulin insensitivity and hyperglyce-3732 KLINDT mia that develops with pST treatment IWrayCahen et al., 1987) . If reduced serum concentrations of IGFBP-2 are obligatory for the growthpromoting effects of pST administration, then the hyperglycemia may also be obligatory.
The endocrine system acts to coordinate the metabolic processes of the animal. Changes in circulating concentrations of ST, a product of the pituitary, which has been referred to as the "master gland" in the past, induces changes in the metabolism of the growing pig, which ultimately results in greater accretion of muscle and reduced accretion of fat. Porcine ST induced changes in circulating hormones and metabolites and size of internal organs as well as changes in accretion of carcass components. Many of these changes were influenced by genotype and sex. Changes in internal organs suggest increased energetic demands for maintenance. The changes measured in serum components and internal organs may be required for pST induction of the desired repartitioning of nutrients obtained with administration of pST-SR. The results reported herein indicate that administration of pST via sustained-release implants is efficacious and results in the desired alternations of carcass accretion.
Implications
Administration of porcine somatotropin by a sustained-release implant increased efficiency of gain and lean deposition and decreased fat deposition in genetically lean and obese barrows and gilts. Improvements in carcass composition were accompanied by increases in weights of internal organs, suggesting increased maintenance requirements.
Most responses to porcine somatotropin were influenced by interactions with line and(or1 sex. The interactions suggest that optimal use of somatotropin as a growth modifier may require tailoring its administration to the genotype and sex of the animal. The internal organ responses suggest that increases in weights of internal organs may be required for the growthmodifying actions of somatotropin on carcass traits.
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